Abstract
University student housing environments are often viewed as hotspots for infectious disease transmission due to their high-density living conditions and high frequency of interpersonal interactions. During the COVID-19 pandemic, concerns arose that on-campus dormitories could serve as amplifiers of viral spread, seeding outbreaks into surrounding off-campus student residences. However, whether on-campus housing acts as a primary driver of transmission or as a recipient of infections introduced from the broader off-campus community remains unresolved. Here, we analyzed 1,431 SARS-CoV-2 genomes collected from students residing on and off campus at the University of North Carolina at Charlotte (UNCC) between September 2020 and May 2022. Using Bayesian phylodynamic and ancestral state reconstruction approaches, we traced viral transmission pathways to determine the directionality of spread between residential settings. Our results indicate that transmission from off-campus housing consistently seeded on-campus dormitory outbreaks. In contrast, viral movement from on-campus to off-campus housing was minimal. These patterns persisted across all major pandemic waves, regardless of shifting mitigation strategies, and suggest that on-campus residences acted as transmission sinks rather than sources of broader student outbreaks. These findings raise the possibility that on-campus residences may be more vulnerable than often considered, functioning as epidemiological islands that primarily receive infections from off-campus sources.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by COVID-19 contract funding from The NC Collaboratory CORVASEQ project (CG and JS), Mecklenburg County Public Health (CG, JS, WT, AH, JF), and the State of North Carolina (CG, JS and AD) and by National Science Foundation of the United States of America RAPID 2031204 (AD). JB was supported by a graduate teaching assistantship from the UNC Charlotte Department of Bioinformatics and Genomics.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research has been approved by the UNC Charlotte Institutional Review Board (IRB protocol 21-0113).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.